[Form 3] Sanara MedTech Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Sanara MedTech Inc. (SMTI) Form 3 shows Ashley M. Mackey reported beneficial ownership of 2,412 shares of the issuer's common stock. The report cites an event date of 08/29/2025 and the form is signed on 09/04/2025. The filing identifies the reporting person as a Director and indicates Controller in the relationship field. No derivative securities or additional holdings are reported.

Positive

• Timely initial disclosure filed for an officer/director/controller, meeting Section 16(a) reporting requirements
• No derivative positions reported, simplifying future monitoring of potential exercises or conversions

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine initial Section 16 filing reporting direct ownership of 2,412 common shares.

This Form 3 appears to be a standard initial disclosure under Section 16(a) documenting Ashley M. Mackey's direct beneficial ownership of 2,412 shares of Sanara MedTech Inc. The filing lists the relevant event date and contains no derivative positions, amendments, or additional material disclosures. For compliance purposes, the form fulfills the basic requirement to report an officer/director/controller's initial holdings.

Corporate Governance Specialist

TL;DR: Initial ownership disclosure only; nothing material to company valuation or control.

The disclosure identifies the reporting person as a director and lists "Controller" in the relationship field while reporting only direct common stock ownership of 2,412 shares. There are no option grants, warrants, convertible securities, or indirect holdings noted. This is a routine governance disclosure that does not indicate changes in control or material transactions.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mackey Ashley M

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TX 76102

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/29/2025

3. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Controller

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,412	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Ashley M. Mackey	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for SMTI disclose?

The Form 3 discloses that Ashley M. Mackey beneficially owns 2,412 shares of Sanara MedTech Inc. common stock and reported the event dated 08/29/2025.

When was the Form 3 for SMTI signed?

The filing is signed by the reporting person on 09/04/2025.

Does the Form 3 report any derivative securities for SMTI?

No. Table II for derivative securities shows no entries; only direct common stock is reported.

What relationship to the issuer is listed for the reporting person on the Form 3?

The form marks the reporting person as a Director and includes Controller in the relationship field.

Is this Form 3 an amendment or an initial filing?

This is an initial Form 3 (Initial Statement of Beneficial Ownership); no amendment date is provided.